Module 2: Completion
Congratulations! You have now completed Module 2: Managing Pain Patients Who Abuse Prescription Drugs (Unaccredited).
To learn more about the safe management of opioid pain medications, please visit Module 1: Safe Prescribing for Pain (Unaccredited).
NIDA offers additional tools and resources for you and your patients, including:
- Additional Screening Resources
- Drug Abuse Information
- Treatment Resources
- Patient Education Materials
NIDA also provides free drug abuse and addiction curriculum resources for faculty, resident physicians, and medical students through NIDA’s Centers of Excellence for Physician Information.
- Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170:1155-1160.
- Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Medicine. 2005;69:432-442.
- Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006;32:287-293.
- Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Volume 1. Summary of National Findings. NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2012
- Centers for Disease Control and Prevention. CDC grand rounds: prescription drug overdoses -- a US epidemic. MMWR Morb Mort Wkly Rep. 2012:61:10-13.
- National Institute on Drug Abuse. Research Report Series: Prescription Drugs: Abuse and Addiction. 2011. https://www.drugabuse.gov/publications/research-reports/misuse-prescription-drugs
- Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77-85.
- Boscarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patinets on opioid therapy in a large US health-care system. Addiction. 2010;105:1776-1782.
- Brown J, Setnik B, Lee K, et al. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J Opioid Manag. 2011;7:467-483.
- Michna E, Ross EL, Hynes WL, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004;28:250-258.
- Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6:107-112.
- Gourlay DL, Heit HA. Universal precautions revisited: managing the inherited pain patient. Pain Med. 2009;10:S115-S123.
- Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943-1953.
- Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA. 2005;293:3043-3052.
- Martell BA, O’Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146:116-127.
- Passik SD, Kirsh KL. Assessing aberrant drug-taking behaviors in the patient with chronic pain. Curr Pain Headache Res. 2004;8:289-294.
- American Medical Association. Informed Consent. American Medical Association 2012. http://www.ama-assn.org/ama/pub/physician-resources/legal-topics/patient-physician-relationship-topics/informed-consent.page?. Accessed 8/9/2012.
- Paterick TJ, Carson GV, Allen MC, Paterick TE. Medical informed consent: general considerations for physicians. Mayo Clin Proc. 2008;83:313-319.
- Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician. 2011;14:123-143.
- McCarberg BH. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management. Postgrad Med. 2011;123:124-131.
- Carroll CP, Haythornthwaite J. Maladaptive opioid use behaviors and psychiatric illness: what should we do with what we know? Curr Pain Headache Rep. 2011;15:91-93.
- Miller NS, Gold MS. Opiate prescription medication dependence and pain perceptions. J Addict Dis. 2007;26(Suppl 1):65-71.
- Weissman DE, Haddox JD. Opioid pseudoaddiction -- an iatrogenic syndrome. Pain. 1989;36:363-366.
- Passik SD, Kirsh KL, Whitcomb L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2007;26:552-561.
- Smith HS, Kirsh KL. Documentation and potential tools in long-term opioid therapy for pain. Anesthesiology Clin. 2007;25:809-823.
- Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130:144-156.
- Weiss RD, Potter JS, Provost SE, et al. A multi-site, two-phase Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology. Contemp Clin Trials. 2010;31:189-199.
- Weiss RD, Potter JS, Fiellin DA, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011;68:1238-1246.